These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23312027)

  • 1. Cyclophilin A inhibition: targeting transition-state-bound enzyme conformations for structure-based drug design.
    Nagaraju M; McGowan LC; Hamelberg D
    J Chem Inf Model; 2013 Feb; 53(2):403-10. PubMed ID: 23312027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational plasticity of an enzyme during catalysis: intricate coupling between cyclophilin A dynamics and substrate turnover.
    McGowan LC; Hamelberg D
    Biophys J; 2013 Jan; 104(1):216-26. PubMed ID: 23332074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Entropic and surprisingly small intramolecular polarization effects in the mechanism of cyclophilin A.
    Ladani ST; Hamelberg D
    J Phys Chem B; 2012 Sep; 116(35):10771-8. PubMed ID: 22891696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What is so special about Arg 55 in the catalysis of cyclophilin A? insights from hybrid QM/MM simulations.
    Li G; Cui Q
    J Am Chem Soc; 2003 Dec; 125(49):15028-38. PubMed ID: 14653737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligopeptide cyclophilin inhibitors: a reassessment.
    Schumann M; Jahreis G; Kahlert V; Lücke C; Fischer G
    Eur J Med Chem; 2011 Nov; 46(11):5556-61. PubMed ID: 21963115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cis/trans isomerization in HIV-1 capsid protein catalyzed by cyclophilin A: insights from computational and theoretical studies.
    Agarwal PK
    Proteins; 2004 Aug; 56(3):449-63. PubMed ID: 15229879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovering potent small molecule inhibitors of cyclophilin A using de novo drug design approach.
    Ni S; Yuan Y; Huang J; Mao X; Lv M; Zhu J; Shen X; Pei J; Lai L; Jiang H; Li J
    J Med Chem; 2009 Sep; 52(17):5295-8. PubMed ID: 19691347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategy for discovering chemical inhibitors of human cyclophilin a: focused library design, virtual screening, chemical synthesis and bioassay.
    Li J; Zhang J; Chen J; Luo X; Zhu W; Shen J; Liu H; Shen X; Jiang H
    J Comb Chem; 2006; 8(3):326-37. PubMed ID: 16677001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A fluorescence polarization-based assay for peptidyl prolyl cis/trans isomerase cyclophilin A.
    Liu Y; Jiang J; Richardson PL; Reddy RD; Johnson DD; Kati WM
    Anal Biochem; 2006 Sep; 356(1):100-7. PubMed ID: 16737676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrinsic dynamics of an enzyme underlies catalysis.
    Eisenmesser EZ; Millet O; Labeikovsky W; Korzhnev DM; Wolf-Watz M; Bosco DA; Skalicky JJ; Kay LE; Kern D
    Nature; 2005 Nov; 438(7064):117-21. PubMed ID: 16267559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational insight into small molecule inhibition of cyclophilins.
    Sambasivarao SV; Acevedo O
    J Chem Inf Model; 2011 Feb; 51(2):475-82. PubMed ID: 21194235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural insights into the catalytic mechanism of cyclophilin A.
    Howard BR; Vajdos FF; Li S; Sundquist WI; Hill CP
    Nat Struct Biol; 2003 Jun; 10(6):475-81. PubMed ID: 12730686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catalysis of cis/trans isomerization in native HIV-1 capsid by human cyclophilin A.
    Bosco DA; Eisenmesser EZ; Pochapsky S; Sundquist WI; Kern D
    Proc Natl Acad Sci U S A; 2002 Apr; 99(8):5247-52. PubMed ID: 11929983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovering novel chemical inhibitors of human cyclophilin A: virtual screening, synthesis, and bioassay.
    Li J; Chen J; Gui C; Zhang L; Qin Y; Xu Q; Zhang J; Liu H; Shen X; Jiang H
    Bioorg Med Chem; 2006 Apr; 14(7):2209-24. PubMed ID: 16307882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probing flexibility and "induced-fit" phenomena in aldose reductase by comparative crystal structure analysis and molecular dynamics simulations.
    Sotriffer CA; Krämer O; Klebe G
    Proteins; 2004 Jul; 56(1):52-66. PubMed ID: 15162486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissecting the catalytic mechanism of a plant beta-D-glucan glucohydrolase through structural biology using inhibitors and substrate analogues.
    Hrmova M; Fincher GB
    Carbohydr Res; 2007 Sep; 342(12-13):1613-23. PubMed ID: 17548065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flexibility and inhibitor binding in cdc25 phosphatases.
    Arantes GM
    Proteins; 2010 Nov; 78(14):3017-32. PubMed ID: 20740493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein conformational populations and functionally relevant substates.
    Ramanathan A; Savol A; Burger V; Chennubhotla CS; Agarwal PK
    Acc Chem Res; 2014 Jan; 47(1):149-56. PubMed ID: 23988159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced molecular dynamics sampling of drug target conformations.
    Rodriguez-Bussey IG; Doshi U; Hamelberg D
    Biopolymers; 2016 Jan; 105(1):35-42. PubMed ID: 26352326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein dynamics and enzymatic catalysis: investigating the peptidyl-prolyl cis-trans isomerization activity of cyclophilin A.
    Agarwal PK; Geist A; Gorin A
    Biochemistry; 2004 Aug; 43(33):10605-18. PubMed ID: 15311922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.